Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Myriad Genetics (MYGN) over the last 14 years, with Q3 2025 value amounting to $6.6 million.

  • Myriad Genetics' Other Non-Current Assets fell 6000.0% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 6000.0%. This contributed to the annual value of $8.5 million for FY2024, which is 4480.52% down from last year.
  • Per Myriad Genetics' latest filing, its Other Non-Current Assets stood at $6.6 million for Q3 2025, which was down 6000.0% from $7.1 million recorded in Q2 2025.
  • Myriad Genetics' Other Non-Current Assets' 5-year high stood at $225.7 million during Q2 2021, with a 5-year trough of $3.6 million in Q1 2021.
  • Over the past 5 years, Myriad Genetics' median Other Non-Current Assets value was $8.8 million (recorded in 2022), while the average stood at $22.8 million.
  • Per our database at Business Quant, Myriad Genetics' Other Non-Current Assets soared by 56666.67% in 2021 and then plummeted by 9610.1% in 2022.
  • Over the past 5 years, Myriad Genetics' Other Non-Current Assets (Quarter) stood at $8.3 million in 2021, then surged by 86.75% to $15.5 million in 2022, then dropped by 0.65% to $15.4 million in 2023, then tumbled by 44.81% to $8.5 million in 2024, then fell by 22.35% to $6.6 million in 2025.
  • Its Other Non-Current Assets stands at $6.6 million for Q3 2025, versus $7.1 million for Q2 2025 and $7.7 million for Q1 2025.